ADAKVEO
Novartis AG
Application Filed: 2011-07-08
Trademark Application Details
IR CANCELLED; US REGISTRATION CANCELLED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79100532 |
| Registration Number | 4152348 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | H |
| Domestic Representative | Novartis Pharmaceuticals Corporation |
| Attorney Name | Maury M. Tepper, III |
| Law Office Assigned | L30 |
| Employee Name | BORSUK, ESTHER A |
Timeline
| 2011-07-08 | Application Filed |
| 2012-03-20 | Published for Opposition |
| 2012-06-05 | Location: PUBLICATION AND ISSUE SECTION |
| 2012-06-05 | Trademark Registered |
| 2018-05-17 | Cancelled |
| 2018-05-17 | Status: Dead/Cancelled |
| 2019-03-01 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Novartis AG |
| Entity Statement | Société anonyme (SA) |
| Address | CH-4002 Basel CH |
| Legal Entity Type | |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives; Vaccines; Diagnostic preparations for medical use |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2011-08-11 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2011-08-15 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2011-08-19 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2011-09-07 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2011-09-13 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2011-09-14 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2011-09-15 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2011-09-15 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2011-10-03 | 9 RFNT P: |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2011-12-12 | 10 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2011-12-12 | 11 ARAA I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2012-01-16 | 12 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2012-01-26 | 13 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2012-02-06 | 14 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2012-02-06 | 15 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2012-02-07 | 16 CNSA O:Outgoing Correspondence |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2012-02-10 | 17 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2012-02-29 | 18 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2012-03-20 | 19 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2012-03-20 | 20 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2012-06-05 | 21 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2012-09-05 | 22 FICR P: |
| FINAL DISPOSITION PROCESSED | 2012-09-10 | 23 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2012-09-10 | 24 FICS P: |
| CHANGE OF NAME/ADDRESS REC'D FROM IB | 2013-02-23 | 25 ADCH M: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2013-03-04 | 26 FINO P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2013-04-13 | 27 NREP P: |
| COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | 2017-06-05 | 28 REM3 E:E-Mail |
| DEATH OF INTERNATIONAL REGISTRATION | 2018-06-01 | 29 DETH P: |
| NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | 2018-06-02 | 30 DENC E:E-Mail |
| NOTIFICATION PROCESSED BY IB | 2019-03-01 | 31 GPNX P: |
| INTERNATIONAL REGISTRATION RENEWED | 2021-08-02 | 32 RNWL P: |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ADAKVEO 79236498 5609269 Live/Registered |
Novartis AG 2018-05-12 |
 ADAKVEO 79100532 4152348 Dead/Cancelled |
Novartis AG 2011-07-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 